Cargando…
Advances with RNAi-Based Therapy for Hepatitis B Virus Infection
Infection with hepatitis B virus (HBV) remains a global health challenge. Approximately 292 million people worldwide are chronically infected with HBV and the annual mortality from the infection is approaching 900,000. Despite the availability of an effective prophylactic vaccine, millions of indivi...
Autores principales: | van den Berg, Fiona, Limani, Shonisani Wendy, Mnyandu, Njabulo, Maepa, Mohube Betty, Ely, Abdullah, Arbuthnot, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472220/ https://www.ncbi.nlm.nih.gov/pubmed/32759756 http://dx.doi.org/10.3390/v12080851 |
Ejemplares similares
-
Advances in designing Adeno-associated viral vectors for development of anti-HBV gene therapeutics
por: Mnyandu, Njabulo, et al.
Publicado: (2021) -
In Vivo Modelling of Hepatitis B Virus Subgenotype A1 Replication Using Adeno-Associated Viral Vectors
por: Limani, Shonisani Wendy, et al.
Publicado: (2021) -
Gene Therapy for Chronic HBV—Can We Eliminate cccDNA?
por: Bloom, Kristie, et al.
Publicado: (2018) -
Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs
por: Maepa, Mohube Betty, et al.
Publicado: (2017) -
Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
por: Ely, Abdullah, et al.
Publicado: (2021)